Fluorescence angiography guided resection of small bowel neuroendocrine neoplasms with mesenteric lymph node

E Kaçmaz1, M D Slooter1, E J M Nieveen van Dijkum2

  • 1Department of Surgery, Amsterdam UMC, University of Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands.

Abstract

Insights

Fluorescence angiography (FA) guided surgery for small bowel neuroendocrine neoplasms (SB-NEN) changed management in 80% of patients. This technique helps tailor bowel resection to preserve or remove tissue based on perfusion, improving outcomes.

Area of Science:

  • Surgical Oncology
  • Gastroenterology
  • Medical Imaging

Background:

  • Surgery for small bowel neuroendocrine neoplasms (SB-NEN) risks vascular compromise of remaining bowel.
  • Lymph node metastases near mesenteric vessels pose a challenge.
  • Fluorescence angiography (FA) is a safe technique for assessing gastrointestinal perfusion.

Purpose of the Study:

  • To evaluate the value of intraoperative FA in SB-NEN surgery.
  • To determine if FA can optimize surgical management and bowel perfusion assessment.

Main Methods:

  • Ten patients undergoing SB-NEN surgery were included.
  • FA using indocyanine green (ICG) was performed after planned transection marking.
  • The primary outcome was any change in surgical management due to FA findings.

Main Results:

  • FA led to management changes in 80% of patients (8 out of 10).
  • Four patients had reduced bowel resection (5-35 cm preserved), while four had extended resections (3-25 cm additional).
  • No anastomotic leakage occurred, with a median postoperative stay of 4 days.

Conclusions:

  • FA is the first described technique for assessing perfusion during SB-NEN surgery.
  • FA significantly altered surgical management in 80% of cases, enabling precise tailoring of bowel resection.
  • Implementing FA improves outcomes by preserving well-perfused bowel or resecting compromised sections.

Related Concept Videos